D-Bose 0.2 Tablet MD
Marketer
Sinsan Pharmaceuticals
Salt Composition
Voglibose (0.2mg)
Overview D-Bose 0.2 Tablet MD
Med-Bose 0.2mg tablets manage type 2 diabetes by regulating post-prandial hyperglycemia. This medication is prescribed when dietary modifications and other anti-diabetic therapies prove insufficient to control elevated blood glucose. Take Med-Bose 0.2mg immediately before meals; dosage and frequency are determined by your physician for optimal glycemic control. Discontinuing this medication abruptly is unsafe; doing so can raise blood sugar, potentially leading to severe complications such as renal impairment and vision loss. This treatment complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management, as directed by your doctor. Regular blood glucose monitoring is crucial. Common side effects include abdominal discomfort (flatulence, pain, loss of appetite), constipation, and diarrhea. Report persistent or troublesome side effects to your doctor. While Med-Bose 0.2mg itself doesn't induce hypoglycemia, concurrent use with other diabetes medications (particularly insulin or sulfonylureas) may increase this risk. Treat hypoglycemic episodes with plain glucose; table sugar is ineffective in this context. Inform your physician of any liver or kidney issues before starting treatment. This medicine is contraindicated in patients with bowel inflammation or ulceration (e.g., Crohn's disease, ulcerative colitis). Pregnant or nursing individuals should seek medical advice. Always disclose all medications you're taking to ensure safe use. Limit alcohol consumption while on this medication to minimize hypoglycemia risk.
Primary Ingredients of D-Bose 0.2 Tablet MD
There is no text provided to rephrase.
Uses of D-Bose 0.2 Tablet MD
Managing Type 2 diabetes
Major Benefits of D-Bose 0.2 Tablet MD:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Avoid contact with the tablets using damp hands. Place the tablet in your mouth, but refrain from swallowing immediately. D-Bose 0.2mg tablets should be taken on an empty stomach.
Common Side effects of D-Bose 0.2 Tablet MD:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use D-Bose 0.2 Tablet MD:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Avoid handling the tablets with damp hands. Place the D-Bose 0.2mg Tablet MD in your mouth, but refrain from swallowing immediately; take it on an empty stomach.
How D-Bose 0.2 Tablet MD works:
D-Bose 0.2 MD tablets are an antidiabetic medication that works by blocking intestinal enzymes. These enzymes normally digest complex carbohydrates into simple sugars like glucose. Consequently, postprandial blood sugar spikes are significantly reduced.
SAFETY ADVICE
AlcoholUNSAFE
Combining D-Bose 0.2 Tablet MD and alcohol is unsafe.
PregnancySAFE IF PRESCRIBED
Use of D-Bose 0.2 Tablet MD during pregnancy is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; nonetheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of D-Bose 0.2 Tablet MD while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by D-Bose 0.2 mg tablets.
KidneyCAUTION
For individuals with severely impaired kidney function, D-Bose 0.2 Tablet MD requires careful administration. Dosage modification of D-Bose 0.2 Tablet MD might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use D-Bose 0.2 Tablet MD cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take D-Bose 0.2 Tablet MD :
Omit any missed D-Bose 0.2 Tablet MD dose and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About D-Bose 0.2 Tablet MD
| Label | Value |
|---|---|
| Chemical Classification | Valiolamine analog |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
| Actions | Alpha-glucosidase inhibitors |





